AudioScholar Hematology Weekly

Welcome to This Week in Hematology. This week we are covering eight notable papers spanning advances in cellular immunotherapies, optimization of plasma cell disorder regimens, and novel risk stratification and supportive care strategies in hematolog… This week's papers: 1. Tagraxofusp, Azacitidine, and Venetoclax in Blastic Plasmacytoid Dendritic Cell Neoplasm. — Blood 2026 2. Concurrent administ...

Welcome to This Week in Hematology. This week we are covering ten notable papers spanning three major areas: myeloid malignancies including myelofibrosis, myelodysplastic syndromes, and acute myeloid leukemia; lymphoid neoplasms featuring chronic lym… This week's papers: 1. TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis. — Blo...

Welcome to This Week in Hematology. This week we are covering nine notable papers spanning advanced cellular therapies and precision monitoring in lymphomas, optimized treatment protocols in chronic lymphocytic leukemia and hemophilia, and novel syst… This week's papers: 1. Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic H...

Welcome to This Week in Hematology. This week we're covering 8 notable papers spanning advances in diagnosing and treating lymphoma, new strategies in thrombosis and hemostasis, and innovations in cellular therapy and infectious disease management. L… This week's papers: 1. Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib...

Welcome to This Week in Hematology. This week we're covering 10 notable papers spanning advances in allogeneic transplant strategies, the growing role of molecular biomarkers in managing hematologic malignancies, and new therapeutic approaches for be… This week's papers: 1. TRACTION for Greater Surgical Use of Tranexamic Acid. — The New England journal of medicine 2026 2. CSF ctDNA Molecular Clear...

Welcome to This Week in Hematology. This week we're covering 8 notable papers spanning new therapeutic strategies in lymphoma and leukemia, fundamental new insights into hemostasis, and a key trial in pediatric hyperinflammation. Let's dive in. [PAU… This week's papers: 1. HLHRUXO: A prospective trial of a ruxolitinib-containing regimen for children with hemophagocytic lymphohistiocytosis. — Blood...

Welcome to This Week in Hematology. This week we're covering seven notable papers spanning measurable residual disease in AML, the fundamental biology of stem cell aging, and clinical challenges in treating hematologic disorders. Let's dive in. [PAU… This week's papers: 1. Real-world heterogeneity in the prognostic value of pre-transplant flow cytometry measurable residual disease in acute myeloid...

Welcome to This Week in Hematology. This week we're covering 10 notable papers spanning new therapeutic targets and prognostic markers in leukemia and myeloma, evolving management strategies in thrombosis, and a major population study reassessing lon… This week's papers: 1. Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort study. — Journal of thrombosis...

Welcome to This Week in Hematology. This week we're covering 10 notable papers spanning new approaches to risk stratification in malignant hematology, real-world data on novel therapies and transplant strategies, and practice-changing findings in ben… This week's papers: 1. Cost-effectiveness of iron deficiency screening in pregnancy across ferritin-based thresholds. — Blood advances 2026 2. Chron...